1. Behl, C., Winkler, J., Bogdahn, U., Meixensberger, J., Schlingensiepen, K.-H., and Brysch, W. (1993). Autocrine growth regulation in neuroectodermal tumors as detected with oligodeoxynucleotide antisense molecules.Neurosurgery 33679–684.
2. Binetruy, B., Smeal, T., and Karin, M. (1991). Ha-ras augments c-Jun activity and stimulates phosphorylation of its activation domain.Nature 351122–127.
3. Brysch, W., Rifai, A., Tischmeyer, W., and Schlingensiepen, K.-H. (1994). Rational drug design, pharmacokinetics, intracerebral application and organ uptake of antisense phosphorothioate oligodeoxynucleotides. In (S. Agrawal, Ed.),Antisense Oligonucleotide Therapy: Current Status, Humana Press, Clifton, NJ (in press).
4. Chiu, R., Angel, P., and Karin, M. (1989). Jun-B differs in its biological properties from and is a negative regulator of c-Jun.Cell 59979–986.
5. Daan, S., and Pittendrigh, C. S. (1976). A functional analysis of circadian pacemakers in nocturnal rodents. II. The variability of phase response curves.J. Comp. Physiol. A 106253–266.